These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34216297)

  • 1. COVID-19 and Myositis: What We Know So Far.
    Saud A; Naveen R; Aggarwal R; Gupta L
    Curr Rheumatol Rep; 2021 Jul; 23(8):63. PubMed ID: 34216297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.
    Viveiros A; Rasmuson J; Vu J; Mulvagh SL; Yip CYY; Norris CM; Oudit GY
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H296-H304. PubMed ID: 33275517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasiform rashes as the first manifestation of anti-MDA5 associated myositis.
    Rathore U; Haldule S; Gupta L
    Rheumatology (Oxford); 2021 Jul; 60(7):3483. PubMed ID: 33284978
    [No Abstract]   [Full Text] [Related]  

  • 4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review.
    Gonzalez D; Gupta L; Murthy V; Gonzalez EB; Williamson KA; Makol A; Tan CL; Sulaiman FN; Shahril NS; Isa LM; Martín-Nares E; Aggarwal R
    Rheumatol Int; 2022 Sep; 42(9):1629-1641. PubMed ID: 35661906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review.
    Tonutti A; Motta F; Ceribelli A; Isailovic N; Selmi C; De Santis M
    Front Immunol; 2022; 13():937667. PubMed ID: 35833112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling.
    Melki I; Devilliers H; Gitiaux C; Bondet V; Duffy D; Charuel JL; Miyara M; Bokov P; Kheniche A; Kwon T; Authier FJ; Allenbach Y; Belot A; Bodemer C; Bourrat E; Dumaine C; Fabien N; Faye A; Frémond ML; Hadchouel A; Kitabayashi N; Lepelley A; Martin-Niclos MJ; Mudumba S; Musset L; Quartier P; Rice GI; Seabra L; Uettwiller F; Uggenti C; Viel S; Rodero MP; Crow YJ; Bader-Meunier B
    Rheumatology (Oxford); 2020 Aug; 59(8):1927-1937. PubMed ID: 31755959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report of COVID-19 in an elderly patient: could SARS-CoV2 trigger myositis?
    Sacchi MC; Tamiazzo S; Lauritano EC; Bonometti R
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11960-11963. PubMed ID: 33275270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and myositis - unique challenges for patients.
    Gupta L; Lilleker JB; Agarwal V; Chinoy H; Aggarwal R
    Rheumatology (Oxford); 2021 Feb; 60(2):907-910. PubMed ID: 33175137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America.
    Mamyrova G; Kishi T; Shi M; Targoff IN; Huber AM; Curiel RV; Miller FW; Rider LG;
    Rheumatology (Oxford); 2021 Apr; 60(4):1839-1849. PubMed ID: 33140079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Disease and Dermatomyositis: A Mini-Review.
    Qian J; Xu H
    Front Immunol; 2021; 12():747116. PubMed ID: 35095837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-onset dermatomyositis following COVID-19: A case report.
    Shimizu H; Matsumoto H; Sasajima T; Suzuki T; Okubo Y; Fujita Y; Temmoku J; Yoshida S; Asano T; Ohira H; Ejiri Y; Migita K
    Front Immunol; 2022; 13():1002329. PubMed ID: 36353621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MDA5 Antibody Spectrum in Western World.
    Moghadam-Kia S; Oddis CV; Aggarwal R
    Curr Rheumatol Rep; 2018 Oct; 20(12):78. PubMed ID: 30382445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies.
    Hou C; Durrleman C; Periou B; Barnerias C; Bodemer C; Desguerre I; Quartier P; Melki I; Rice GI; Rodero MP; Charuel JL; Relaix F; Bader-Meunier B; Authier F; Gitiaux C
    Arthritis Rheumatol; 2021 Jun; 73(6):1044-1052. PubMed ID: 33314705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of anti-HMGCR and anti-MDA5 identified by an unlabeled immunoprecipitation assay in a chinese patient cohort with myositis.
    Huang L; Wang L; Yang Y; Chen H; Liu Y; Liu K; Liu M; Xiao Y; Zuo X; Li Y; Luo H; Zhang H; Xiao X
    Medicine (Baltimore); 2018 Nov; 97(47):e13236. PubMed ID: 30461626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.
    Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32518172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.
    Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A
    Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies.
    Nombel A; Fabien N; Coutant F
    Front Immunol; 2021; 12():773352. PubMed ID: 34745149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.